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Analysis of Risk Factors in Hypertension Patients with Chronic Kidney
Disease Stage 5
Li Qiu Yue, Chen Qin Kai
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi,
China
Objective: To analyse the risk factors for hypertension patients with chronic
kidney disease stage 5 (CKD5).
Methods: Collecting 390 hypertension patients with CKD5, recording the
basic information. Gender, age, primary disease, dialysis method, BMI, com-
plications (hyperlipidemia, high uric acid, cardiac insufficiency), level of ed-
ucation, PTH were first examined by using univariate analysis. Univariate
variables that showed statistical significance were then subjected to the
multivariate analysis (logistic regression) to identify the risk factors for hy-
pertension patients with CKD5; evaluating the level of DDD according to hy-
pertension segmented standard;
Results: Overall hypertension control rate is 22.8%. (1) Univariate analysis
showed the following variables had significant differences: > 40 years old,
male, diabetic nephropathy, hypertensive nephropathy, hemodialysis, hyperli-
pemia, highPTH(P<0.05). (2) Logisticmultivariateanalysis showed that diabetic
nephropathy, hyperlipidemia, high PTHwere themajor risk factors for hyperten-
sion patients with CKD5. (3) In hypertension segmented standard, the level of
DDD was no different between 0 and 1 standard (P>0.05), DDD of 2 and 3 para-
graphswere increased significantly compared with 0 and 1 paragraphs (P<0.05).
Conclusion: Overall hypertension control rate is only 22.8% in hypertension
patients with CKD 5. Diabetic nephropathy, hyperlipidemia and high PTH are
independent risk factors in hypertension patients with CKD5.http://dx.doi.org/10.1016/j.hkjn.2015.08.0690009
Nonapnea Sleep Disorders and the Risk of Acute Kidney Injury: A
Population-based Retrospective Cohort Study
Hugo You-Hsien Lin1,2,3, Kai-Ting Chang2,3, Yu-Han Chang2,3,
Chi-Chih Hung1,3, Hung-Chun Chen1,3, Shang-Jyh Hwang1,3
1Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
2Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan
3Kaohsiung Medical University, Kaohsiung, Taiwan
Objective: Nonapnea sleep disorders (NASD) and sleep-related problems,
which are high prevalent in patients with kidney diseases, are associated
with cardiovascular disease, type 2 diabetes mellitus (DM) and chronic kidney
disease (CKD). However, whether NASD is associated with acute kidney injury
(AKI) development and prognosis have not been thoroughly investigated. The
aim of this study is to determine whether NASD is an independent risk factor of
AKI by using the database of National Health Insurance Research Database
(NHIRD), which is one of the largest medical databases of the world.
Methods: The retrospective study used an 11-year nationwide database,
which random sampled of 1,000,000 individuals covered by the National
Health Insurance in Taiwan, to analyze the incidence. The patients with1561-5413NASD were identified through diagnostic and medication codes. Kaplan-
Meier and Cox regression analyses were performed.
Results: From 2000 to 2010, 9,316 newly diagnosed NASD cases compared with
27,948 control participants without sleep disorders randomly selected, fre-
quencymatchedbyage, sex, indexyear fromthegeneralpopulation.Wedemon-
strated that the NASD cohort had an adjusted hazard ratio (HR; 95% confidence
interval [CI]Z 1.16e1.71) of subsequent AKI 1.44-fold higher than that of the
cohort without sleep disorders. Elder age, lowermonthly income, hypertension,
DM, cerebrovascular disease, CKD status, depression andhigher Charlson comor-
bidity index were significant factors associated with the increased risk of AKI
(p<0.05). Male and younger (age< 65 year-old) female increased significant
risk of AKI development with NASD (HRZ2.23; 95% CIZ 1.57e3.16, p<0.001).
Conclusion: This nationwide population-based cohort study provides evi-
dence that patients with NASD are at higher risk of developing AKI than peo-
ple without NASD.http://dx.doi.org/10.1016/j.hkjn.2015.08.0700039
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Fibrosis by Enhancing the ERK1/2 MAPK-Smad3 Crosstalk Pathway
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Objective: Angiotensin II (Ang II) has been recognized as a key mediator in
chronic kidney disease (CKD), particularly in hypertension-associated nephrop-
athy. Increasing evidence shows that the angiotensin-converting enzyme 2
(ACE2)/Ang1-7/Mas receptor (Mas) axis plays a protective role in CKD by
counter-regulating the pathogenic actions of the ACE/Ang II/Ang II type 1 re-
ceptor (AT1) axis. In this study, we investigated the role and underlying mech-
anisms of the ACE2/Ang 1-7/Mas axis in Ang II-mediated renal injury.
Methods: A mouse model of hypertension was induced in ACE2 knockout
(KO), Mas KO, double ACE2/Mas KO and their littermate wild-type (WT)
mice by subcutaneous infusion of Ang II (1.0 mg/kg/day) or control saline
for 28 days via osmotic mini-pumps. Blood pressure, serum creatinine (Scr)
and creatinine clearance (Ccr), renal fibrosis including a-SMA and collagen
matrix deposition, and signaling pathways related to Ang II-mediated renal
fibrosis including ERK/MAP kinase and TGF-b/Smad signaling were examined.
Results: Deletion of ACE2 or Mas developed higher levels of blood pressure
compared to WT mice, which was further increased in mice with double
ACE2/Mas deletion at day 7 after Ang II infusion. Moreover, compared to sin-
gle ACE2 or Mas KO mice, mice with double ACE2/Mas KO developed more
severe hypertensive nephropathy as demonstrated by higher levels of Scr,
a fall in Ccr, and progressive renal fibrosis with a marked accumulation of
a-SMA+ myofibroblasts and collagen I matrix. Further study revealed that
the development of more severe kidney injury in double ACE2/Mas KO
mice was associated with enhanced AT1-dependent activation of ERK/MAP
kinase-Smad3 crosstalk pathway.
Hypertensive Nephropathy S23Conclusion: Double knockout of ACE2/Mas largely promotes Ang II-induced
hypertensive nephropathy. Enhanced activation of AT1-dependent ERK/
MAPK-Smad3 signaling may be a mechanism by which disruption of the
ACE2/Ang1-7/Mas axis enhances Ang II-induced renal fibrosis.http://dx.doi.org/10.1016/j.hkjn.2015.08.071
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Supplementation with Aspartic Acid Increases Renal Nitric Oxide and
Attenuates Salt-sensitive Hypertension in Dahl Salt-sensitive Rats
Entai Hou, Le Wang, Fuchang Zhang, Zhongmin Tian
Xi’an Jiaotong University, Xi’an, China
Objective: NO deficiency is associated with development of salt-sensitive hy-
pertension. NO production is limited by the capacity of the kidney to regen-
erate endogenous arginine through the citrulline-NO pathway. High salt
loading causes a deficiency in arginine availability which affects NO synthases
in Dahl salt-sensitive (SS) rats. However, it is not clear why arginine in the kid-
ney of SS rats reducedwith high salt diet. Our previous research found that the
activity of fumarase was lower in the kidney of SS compared with SS.13BN rats.
The current studywill determinewhether decreased renal fumarase activity is
associated with decreased endogenous arginine synthesis and whether
aspartic acid supplementation has antihypertensive effects in SS rats.
Methods:Theexpressionof therate-limitingenzyme involved in thecitrulline-NO
pathwayandthecontentofNOweremeasuredbybiochemical analysis.The level
of aminoacid in kidneywas analysedbyGC-MS. To determinewhether decreased
fumarase activity in SS rat kidney is associatedwith reducedendogenousarginine
synthesis, theexpressionof fumarasewasknockeddown inHK-2cellsusing siRNA.
Then we tested whether supplementation of SS rats with aspartic acid could in-
crease renal arginine and attenduate salt-sensitive hypertension.
Results: The results indicated that protein expression of argininosuccinate syn-
thase (ASS1), argininosuccinate lyaseand the levels ofaspartic acid,arginineand
NO were significantly reduced in the kidney of SS rats compared with SS.13BN
rats. Reducing fumarase expression in HK-2 cells is associated with decreased
arginine and NO level. Further, supplementation of aspartic acid to SS rats on
an 8% NaCl diet increased renal NO and attenuated salt-sensitive hypertension.
Conclusion: The reduction of fumarase activity contributes to reduced arginine
synthesis andelevates thebloodpressureofSSrats. Increasingdeliveryofaspartic
acid to SS rats may be a novel way of supporting renal arginine availability.http://dx.doi.org/10.1016/j.hkjn.2015.08.0720048
Mitochondria Dysfunction in Renal Medulla and Cortex Contribute to
Salt-induced Hypertension in SS Rats
Wang Zhenjun, Sun Na, He Liqin, Tian Zhongmin
Xi’an Jiaotong University, Xi’an, China
Objective: The kidney plays a critical role in the normal control of arterial
blood pressure and in its elevation in salt induced hypertension. Mitochon-
drial dysfunction has been increasingly associated with the development
of hypertension. Here, we amied whether mitochondrial dysfunction occurs
in renal medulla and cortex before hypertension and involves in the eleva-
tion of blood pressure of SS rats?
Methods: Mitochondria were isolated from renal medulla and cortex of the
SS and SS.13BN rats on 0.4% NaCl diet and the function and metabolism of
mitochondria were measured by biochemistry analysis and GC-MS.
Results: The results showed that the activities of fumarase, isocitrate dehydro-
genase, and ketoglutarate dehydrogenase were decreased in renal mitochon-
drial of SS rats compared with SS.13BN rats. The production rate of ATP in SS
was lower than that in SS.13BN rats (0.326 0.030 in SS vs. 0.439 0.050 mmol
ATP/min/mg protein in SS.13BN medulla), and the ATP production rate were
further decreased in SS rats with a high salt diet. Meanwhile, lower levels of pu-
rinenucleotides andhigher levels of aminoacids, including L-alanine, L-leucine,
L-valine and DL-isoleucine were observed in SS rats’ mitochondria. Further die-
tary intervention experiments demonstrated that exogenous ATP supplements
in the water significantly attenuated hypertension (126 2 mmHg ATP + 8%
NaCl vs. 136 3 mmHg 8% NaCl) in SS rats after 10 days.Conclusion: Those data indicated dysfunction of mitochondria in renal me-
dulla and cortex in SS rats. And current research suggests that the decreased
of renal mitochondrial energy metabolism may contribute to salt-induced
hypertension in SS rats.http://dx.doi.org/10.1016/j.hkjn.2015.08.0730058
Reduction of Polyamine Depletion Protects Against Renal
Tubulointerstitial Fibrosis Induced by Hypertensive Nephropathy
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Hypertensive nephropathy is the leading cause of chronic kidney disease
second to diabetic nephropathy. Angiotensin II (AngII) induces tubulointer-
stitial fibrosis, a hallmark of hypertensive nephropathy. Our laboratory
previously reported that suppressing Azin1 via a Smad3-dependent miR-433
pathway not only depletes cellular polyamine levels but also forms a
positive-feedback loop of TGF-b signaling. This study aimed to investigate
the role of polyamines in AngII-mediated hypertensive nephropathy. Results
from in vitro studies demonstrated that treatment of AngII on rat epithelial
cells, NRK52E, depleted the cellular polyamine levels and regulated expres-
sion of Azin1, antizyme and miR-433. Depletion of polyamine enhanced
AngII-induced expression of pro-fibrotic genes and activation of TGF-b
signaling while treatment with polyamine abolished such effects. The reduc-
tion of polyamine depletion by overexpressing Azin1 and suppressing either
antizyme or miR-433 inhibited AngII-induced fibrosis and activation of TGF-b
signaling. These findings were further validated in a mouse model of hyper-
tensive nephropathy. At four weeks after nephrectomy, the renal polyamine
depletion was positively correlated with miR-433 expression but negatively
correlated with Azin1. Restoring Azin1 expression or suppressing miR-433
in remnant kidneys was capable of reducing the renal polyamine depletion,
blocking renal interstitial fibrosis, and inhibiting TGF-b/Smad3 signaling. In
addition, the reciprocal renal expression of miR-433 and Azin1 was observed
in patients with hypertensive nephropathy. In conclusion, regulating cellular
polyamine levels via Azin1 and miR-433 is a new pathway for AngII to induce
renal fibrosis and demonstrates a protective role of polyamines in renal
injury.http://dx.doi.org/10.1016/j.hkjn.2015.08.074
